A recent Center for International Blood and Marrow Transplant Research (CIBMTR) report showed that our BMT program had the highest patient severity score among the largest U.S. transplant centers in good standing. Still, our overall outcomes are excellent.
Category Archives: BMT Program News
The Humor Prescription: One Man’s Journey Through Cancer and Transplant
Michael Butts, an avid fly fisher, swimmer and outdoorsman, spent over 30 years working 12-hour days as a construction site manager, considered by many as a “legend” in his field. Always one to seek out a challenge, Michael studied and received more certifications than anyone else at his company. For years, working in the harsh outside elements never affected him until he noticed a new trend. Even after a long hot shower, he could not warm up after a long day out in the cold. He knew something was wrong. His wife encouraged him to see a doctor and with just one word – “cancer” – his life was forever changed.
Dr. Alexandra Gomez Chosen as European Society for Blood and Marrow Transplantation 2018 Young Ambassador
Dr. Alexandra Gomez, Hematology and Oncology Fellow at Weill Cornell Medicine and New-York Presbyterian (WCM/NYP), was named one of ten 2018 Young Ambassadors of the European Society for Blood and Marrow Transplantation’s (EBMT). EBMT’s Young Ambassador Program highlights talented, rising star scientists, doctors and nurses specializing in the field of bone marrow transplant.
Wishing our Patients Well in 2018
Our Bone Marrow and Stem Cell Transplant (BMT) team and in-patient oncology staff wished our patients and families a healthy and peaceful 2018 by spreading holiday cheer with a roaming cart filled with sweet treats.
Bone Marrow and Stem Cell Transplant Program Research Updates at the 2017 American Society of Hematology Annual Meeting
The Weill Cornell Medicine and NewYork-Presbyterian Bone Marrow and Stem Cell Transplant Program researchers and physicians made a vast impact at this year’s American Society of Hematology (ASH) Annual Meeting and Exposition, an educational gathering of over 25,000 clinicians and scientists from around the world who are working to conquer blood disease.
Stem Cell Transplantation for Sickle Cell Disease: The Only Therapy to Potentially Cure the Disease
Sickle cell disease (SSD) is a genetically inherited disease affecting the red blood cells, causing them to change from a normal round form to a twisted shape. This adversely impacts their ability to carry oxygen throughout the body, and makes the cells more susceptible to be destroyed easily which can cause severe anemia.
Kerry McDuffee Receives DAISY Award for Extraordinary Nursing
Kerry McDuffee, an inpatient nurse within the Weill Cornell Medicine and NewYork-Presbyterian (WCM/NYP) Bone Marrow and Stem Cell Transplant Program, was named a June 2017 DAISY Award Honoree in recognition of the care and compassion that she provides patients and their families.